Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12873)
All Articles published online
|
Publishing Process of This Article
|
Feb 10, 2016 (publication date) through Jan 13, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Long JP, Li XN, Zhang F. Targeting metabolism in breast cancer: How far we can go? World J Clin Oncol 2016; 7(1): 122-130 [PMID: 26862496 DOI: 10.5306/wjco.v7.i1.122] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v7/i1/122.htm |
| Number | Citing Articles |
| 1 |
Fariba Jousheghany, Joshua Phelps, Tina Crook, Reza Hakkak. Relationship between level of HbA1C and breast cancer. BBA Clinical 2016; 6: 45 doi: 10.1016/j.bbacli.2016.04.005
|
| 2 |
Yunfei Li, Brock Humphries, Chengfeng Yang, Zhishan Wang. Nanoparticle-Mediated Therapeutic Agent Delivery for Treating Metastatic Breast Cancer—Challenges and Opportunities. Nanomaterials 2018; 8(6): 361 doi: 10.3390/nano8060361
|
| 3 |
Jinbo Wu, Hongjun Liu, Taobo Hu, Shu Wang. Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database. Hereditas 2022; 159(1) doi: 10.1186/s41065-022-00230-3
|
| 4 |
Ilze Mentoor, A-M Engelbrecht, Theo Nell. Fatty acids: Adiposity and breast cancer chemotherapy, a bad synergy?. Prostaglandins, Leukotrienes and Essential Fatty Acids 2019; 140: 18 doi: 10.1016/j.plefa.2018.11.009
|
| 5 |
Elena López-Camacho, Lucía Trilla-Fuertes, Angelo Gámez-Pozo, Irene Dapía, Rocío López-Vacas, Andrea Zapater-Moros, María Isabel Lumbreras-Herrera, Pedro Arias, Pilar Zamora, Juan Ángel Fresno Vara, Enrique Espinosa. Synergistic effect of antimetabolic and chemotherapy drugs in triple-negative breast cancer. Biomedicine & Pharmacotherapy 2022; 149: 112844 doi: 10.1016/j.biopha.2022.112844
|
| 6 |
Tomas Bertok, Veronika Pinkova Gajdosova, Aniko Bertokova, Natalia Svecova, Peter Kasak, Jan Tkac. Breast cancer glycan biomarkers: their link to tumour cell metabolism and their perspectives in clinical practice. Expert Review of Proteomics 2021; 18(10): 881 doi: 10.1080/14789450.2021.1996231
|
| 7 |
Jiachen Li, Jianmin Pan, Yang Liu, Xiaohui Luo, Cheng Yang, Wangfa Xiao, Qishang Li, Lihui Yang, Xiaodong Zhang. 3‑Bromopyruvic acid regulates glucose metabolism by targeting the c‑Myc/TXNIP axis and induces mitochondria‑mediated apoptosis in TNBC cells. Experimental and Therapeutic Medicine 2022; 24(2) doi: 10.3892/etm.2022.11447
|
| 8 |
Federico Lucantoni, Heiko Dussmann, Jochen H. M. Prehn. Metabolic Targeting of Breast Cancer Cells With the 2-Deoxy-D-Glucose and the Mitochondrial Bioenergetics Inhibitor MDIVI-1. Frontiers in Cell and Developmental Biology 2018; 6 doi: 10.3389/fcell.2018.00113
|
| 9 |
Elena Gennadyevna Varlamova. Protein–protein interactions of ER–resident selenoproteins with their physiological partners. Biochimie 2020; : 197 doi: 10.1016/j.biochi.2020.03.012
|
| 10 |
Eric Achiborebador Okrah, Qiang Wang, Hexiu Fu, Qiuyun Chen, Jing Gao. PdpaMn inhibits fatty acid synthase-mediated glycolysis by down-regulating PI3K/Akt signaling pathway in breast cancer. Anti-Cancer Drugs 2020; 31(10): 1046 doi: 10.1097/CAD.0000000000000968
|
| 11 |
Tarcisio Passos Ribeiro de Campos, Ilza Dalmazio, Rodiney Augusti, Iassudara Garcia Almeida. Gd-GLU toward NMR imaging: synthesis, characterization and breast cell uptake assay. Brazilian Journal of Pharmaceutical Sciences 2020; 56 doi: 10.1590/s2175-97902019000318122
|
| 12 |
Federica Giugliano, Laura Boldrini, Jacopo Uliano, Edoardo Crimini, Ida Minchella, Giuseppe Curigliano. Breast Cancer Research and Treatment. Cancer Treatment and Research 2023; 188: 199 doi: 10.1007/978-3-031-33602-7_8
|
| 13 |
Amrita Basu, Krithika Kodumudi. Multimodal Approaches to Improve Immunotherapy in Breast Cancer. Immunotherapy 2020; 12(3): 161 doi: 10.2217/imt-2019-0198
|
| 14 |
Zhiqiang Guo, Karl-Frédérik Bergeron, Marine Lingrand, Catherine Mounier. Unveiling the MUFA–Cancer Connection: Insights from Endogenous and Exogenous Perspectives. International Journal of Molecular Sciences 2023; 24(12): 9921 doi: 10.3390/ijms24129921
|
| 15 |
Changyuan Wang, Xiaokui Huo, Lijuan Wang, Qiang Meng, Zhihao Liu, Qi Liu, Huijun Sun, Pengyuan Sun, Jinyong Peng, Kexin Liu. Dioscin strengthens the efficiency of adriamycin in MCF-7 and MCF-7/ADR cells through autophagy induction: More than just down-regulation of MDR1. Scientific Reports 2016; 6(1) doi: 10.1038/srep28403
|
| 16 |
Amanda Peterson, Adam Walker, Erica Sloan, Darren Creek. Optimized Method for Untargeted Metabolomics Analysis of MDA-MB-231 Breast Cancer Cells. Metabolites 2016; 6(4): 30 doi: 10.3390/metabo6040030
|
| 17 |
Meritxell Arenas, Elisabet Rodríguez, Anabel García-Heredia, Salvador Fernández-Arroyo, Sebastià Sabater, Rogelio Robaina, Marina Gascón, Maria Rodríguez-Pla, Noemí Cabré, Fedra Luciano-Mateo, Anna Hernández-Aguilera, Isabel Fort-Gallifa, Jordi Camps, Jorge Joven, Gabriele Multhoff. Metabolite normalization with local radiotherapy following breast tumor resection. PLOS ONE 2018; 13(11): e0207474 doi: 10.1371/journal.pone.0207474
|
| 18 |
Rhuthuparna Malayil, Yogita Chhichholiya, Kanika Vasudeva, Harsh Vikram Singh, Tashvinder Singh, Sandeep Singh, Anjana Munshi. Oncogenic metabolic reprogramming in breast cancer: focus on signaling pathways and mitochondrial genes. Medical Oncology 2023; 40(6) doi: 10.1007/s12032-023-02037-2
|
| 19 |
Jeevan K. Prasain, Landon S. Wilson, Clinton Grubbs, Stephen Barnes. Gamma-ray Irradiation of Rodent Diets Alters the Urinary Metabolome in Rats with Chemically Induced Mammary Cancer. Metabolites 2022; 12(10): 976 doi: 10.3390/metabo12100976
|
| 20 |
Meng-Chi Yen, Jung-Yu Kan, Chia-Jung Hsieh, Po-Lin Kuo, Ming-Feng Hou, Ya-Ling Hsu. Association of long-chain acyl-coenzyme A synthetase 5 expression in human breast cancer by estrogen receptor status and its clinical significance. Oncology Reports 2017; 37(6): 3253 doi: 10.3892/or.2017.5610
|
| 21 |
Anna Michel, Thiemo Dinger, Marvin Darkwah Oppong, Laurèl Rauschenbach, Cornelius Deuschl, Yahya Ahmadipour, Daniela Pierscianek, Karsten Wrede, Jörg Hense, Christoph Pöttgen, Antonella Iannaccone, Rainer Kimmig, Ulrich Sure, Ramazan Jabbarli. Radiographic markers of breast cancer brain metastases: relation to clinical characteristics and postoperative outcome. Acta Neurochirurgica 2022; 164(2): 439 doi: 10.1007/s00701-021-05026-4
|
| 22 |
Yan Zhang, Kun Dai, Dedong Xu, Hua Fan, Nannan Ji, Di Wang, Yunlu Zhao, Rui Liu. Saikosaponin A alleviates glycolysis of breast cancer cells through repression of Akt/STAT3 pathway. Chemical Biology & Drug Design 2023; 102(1): 115 doi: 10.1111/cbdd.14259
|
| 23 |
Oliver K. Glass, Michelle Bowie, Julie Fuller, David Darr, Jerry Usary, Keara Boss, Kingshuk Roy Choudhury, Xioajing Liu, Zoe Zhang, Jason W. Locasale, Christina Williams, Mark W. Dewhirst, Lee W. Jones, Victoria Seewaldt. Differential response to exercise in claudin-low breast cancer. Oncotarget 2017; 8(60): 100989 doi: 10.18632/oncotarget.21054
|
| 24 |
Lingling Wang, Shizhen Zhang, Xiaochen Wang. The Metabolic Mechanisms of Breast Cancer Metastasis. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.602416
|
| 25 |
Ilze Mentoor, Anna-Mart Engelbrecht, Paul J. van Jaarsveld, Theo Nell. Chemoresistance: Intricate Interplay Between Breast Tumor Cells and Adipocytes in the Tumor Microenvironment. Frontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00758
|
| 26 |
Mengmeng Chang, Qingqing Wang, Wangshu Qin, Xianzhe Shi, Guowang Xu. Rational Synthesis of Aptamer-Functionalized Polyethylenimine-Modified Magnetic Graphene Oxide Composites for Highly Efficient Enrichment and Comprehensive Metabolomics Analysis of Exosomes. Analytical Chemistry 2020; 92(23): 15497 doi: 10.1021/acs.analchem.0c03374
|
| 27 |
Soheila Delgir, Milad Bastami, Khandan Ilkhani, Asma Safi, Farhad Seif, Mohammad Reza Alivand. The pathways related to glutamine metabolism, glutamine inhibitors and their implication for improving the efficiency of chemotherapy in triple-negative breast cancer. Mutation Research/Reviews in Mutation Research 2021; 787: 108366 doi: 10.1016/j.mrrev.2021.108366
|
| 28 |
Masataka Torigoe, Shigeru Iwata, Shingo Nakayamada, Kei Sakata, Mingzeng Zhang, Maiko Hajime, Yusuke Miyazaki, Manabu Narisawa, Koji Ishii, Hirotaka Shibata, Yoshiya Tanaka. Metabolic Reprogramming Commits Differentiation of Human CD27+IgD+ B Cells to Plasmablasts or CD27−IgD− Cells. The Journal of Immunology 2017; 199(2): 425 doi: 10.4049/jimmunol.1601908
|
| 29 |
Gerald Davies, Liubov Lobanova, Wojciech Dawicki, Gary Groot, John R. Gordon, Matthew Bowen, Troy Harkness, Terra Arnason, Aamir Ahmad. Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer. PLOS ONE 2017; 12(12): e0187191 doi: 10.1371/journal.pone.0187191
|
| 30 |
Mai Ahmed Shafei, Arwa Flemban, Carl Daly, Paul Kendrick, Paul White, Sarah Dean, David Qualtrough, Myra E. Conway. Differential expression of the BCAT isoforms between breast cancer subtypes. Breast Cancer 2021; 28(3): 592 doi: 10.1007/s12282-020-01197-7
|
| 31 |
Eva Baranovicova, Peter Racay, Pavol Zubor, Marek Smolar, Eva Kudelova, Erika Halasova, Dana Dvorska, Zuzana Dankova. Circulating metabolites in the early stage of breast cancer were not related to cancer stage or subtypes but associated with ki67 level. Promising statistical discrimination from controls. Molecular and Cellular Probes 2022; 66: 101862 doi: 10.1016/j.mcp.2022.101862
|
| 32 |
Fereydoon Abedi-Gaballu, Elham Kamal Kazemi, Seyed Ahmad Salehzadeh, Behnaz Mansoori, Farhad Eslami, Ali Emami, Gholamreza Dehghan, Behzad Baradaran, Behzad Mansoori, William C. Cho. Metabolic Pathways in Breast Cancer Reprograming: An Insight to Non-Coding RNAs. Cells 2022; 11(19): 2973 doi: 10.3390/cells11192973
|
| 33 |
Hyein Jeon, Jae Hwan Kim, Eunjung Lee, Young Jin Jang, Joe Eun Son, Jung Yeon Kwon, Tae-gyu Lim, Sunghoon Kim, Jung Han Yoon Park, Jong-Eun Kim, Ki Won Lee. Methionine deprivation suppresses triple-negative breast cancer metastasisin vitroandin vivo. Oncotarget 2016; 7(41): 67223 doi: 10.18632/oncotarget.11615
|
| 34 |
Silvia Cecilia Pacheco-Velázquez, Diana Xochiquetzal Robledo-Cadena, Ileana Hernández-Reséndiz, Juan Carlos Gallardo-Pérez, Rafael Moreno-Sánchez, Sara Rodríguez-Enríquez. Energy Metabolism Drugs Block Triple Negative Breast Metastatic Cancer Cell Phenotype. Molecular Pharmaceutics 2018; 15(6): 2151 doi: 10.1021/acs.molpharmaceut.8b00015
|
| 35 |
Angelica Avagliano, Maria Rosaria Ruocco, Federica Aliotta, Immacolata Belviso, Antonello Accurso, Stefania Masone, Stefania Montagnani, Alessandro Arcucci. Mitochondrial Flexibility of Breast Cancers: A Growth Advantage and a Therapeutic Opportunity. Cells 2019; 8(5): 401 doi: 10.3390/cells8050401
|
| 36 |
Veerle W. Daniels, Jason J. Zoeller, Nick van Gastel, Kelley E. McQueeney, Salma Parvin, Danielle S. Potter, Geoffrey G. Fell, Vinícius G. Ferreira, Binyam Yilma, Rajat Gupta, Johan Spetz, Patrick D. Bhola, Jennifer E. Endress, Isaac S. Harris, Emanuel Carrilho, Kristopher A. Sarosiek, David T. Scadden, Joan S. Brugge, Anthony Letai. Metabolic perturbations sensitize triple-negative breast cancers to apoptosis induced by BH3 mimetics. Science Signaling 2021; 14(686) doi: 10.1126/scisignal.abc7405
|
| 37 |
Zainab Al-Taie, Mark Hannink, Jonathan Mitchem, Christos Papageorgiou, Chi-Ren Shyu. Drug Repositioning and Subgroup Discovery for Precision Medicine Implementation in Triple Negative Breast Cancer. Cancers 2021; 13(24): 6278 doi: 10.3390/cancers13246278
|
| 38 |
Mengping Jiang, Xiangyan Wu, Shengnan Bao, Xi Wang, Fei Qu, Qian Liu, Xiang Huang, Wei Li, Jinhai Tang, Yongmei Yin. Immunometabolism characteristics and a potential prognostic risk model associated with TP53 mutations in breast cancer. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.946468
|
| 39 |
Marina Rosso, Lara Lapyckyj, María José Besso, Marta Monge, Jaume Reventós, Francesc Canals, Jorge Oswaldo Quevedo Cuenca, María Laura Matos, Mónica Hebe Vazquez-Levin. Characterization of the molecular changes associated with the overexpression of a novel epithelial cadherin splice variant mRNA in a breast cancer model using proteomics and bioinformatics approaches: identification of changes in cell metabolism and an increased expression of lactate dehydrogenase B. Cancer & Metabolism 2019; 7(1) doi: 10.1186/s40170-019-0196-9
|
| 40 |
Shawn P. Kubli, Christian Bassi, Cecilia Roux, Andrew Wakeham, Christoph Göbl, Wenjing Zhou, Soode Moghadas Jafari, Bryan Snow, Lisa Jones, Luis Palomero, Kelsie L. Thu, Luca Cassetta, Daniel Soong, Thorsten Berger, Parameswaran Ramachandran, Shakiba P. Baniasadi, Gordon Duncan, Moshit Lindzen, Yosef Yarden, Carmen Herranz, Conxi Lazaro, Mandy F. Chu, Jillian Haight, Paul Tinto, Jennifer Silvester, David W. Cescon, Anna Petit, Sven Pettersson, Jeffrey W. Pollard, Tak W. Mak, Miguel A. Pujana, Paola Cappello, Chiara Gorrini. AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer. Proceedings of the National Academy of Sciences 2019; 116(9): 3604 doi: 10.1073/pnas.1815126116
|
| 41 |
Ganfei Xu, Juan Yu, Jiacheng Lyu, Mengna Zhan, Jie Xu, Minjing Huang, Rui Zhao, Yan Li, Jiajun Zhu, Jinwen Feng, Subei Tan, Peng Ran, Zhenghua Su, Xinhua Liu, Jianyuan Zhao, Hongwei Zhang, Chen Xu, Jun Chang, Yingyong Hou, Chen Ding. Proteogenomic Landscape of Breast Ductal Carcinoma Reveals Tumor Progression Characteristics and Therapeutic Targets. Advanced Science 2024; 11(46) doi: 10.1002/advs.202401041
|
| 42 |
M. Arenas, S. Fernández-Arroyo, E. Rodríguez-Tomàs, S. Sabater, Y. Murria, M. Gascón, K. Amillano, M. Melé, J. Camps, J. Joven. Effects of radiotherapy on plasma energy metabolites in patients with breast cancer who received neoadjuvant chemotherapy. Clinical and Translational Oncology 2020; 22(7): 1078 doi: 10.1007/s12094-019-02232-6
|
| 43 |
Marina Fukano, Morag Park, Geneviève Deblois. Metabolic Flexibility Is a Determinant of Breast Cancer Heterogeneity and Progression. Cancers 2021; 13(18): 4699 doi: 10.3390/cancers13184699
|
| 44 |
Luisa Matos Do Canto, Catalin Marian, Rency S. Varghese, Jaeil Ahn, Patricia A. Da Cunha, Shawna Willey, Mary Sidawy, Janice D. Rone, Amrita K. Cheema, George Luta, Mohammad R. Nezami ranjbar, Habtom W. Ressom, Bassem R. Haddad. Metabolomic profiling of breast tumors using ductal fluid. International Journal of Oncology 2016; 49(6): 2245 doi: 10.3892/ijo.2016.3732
|
| 45 |
Vera Cappelletti, Egidio Iorio, Patrizia Miodini, Marco Silvestri, Matteo Dugo, Maria Grazia Daidone. Metabolic Footprints and Molecular Subtypes in Breast Cancer. Disease Markers 2017; 2017: 1 doi: 10.1155/2017/7687851
|
| 46 |
Tieying Dong, Zhaoliang Liu, Qijia Xuan, Zhuozhong Wang, Wenjie Ma, Qingyuan Zhang. Tumor LDH-A expression and serum LDH status are two metabolic predictors for triple negative breast cancer brain metastasis. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-06378-7
|
| 47 |
Boya Manasa Sai, Yirivinti Hayagreeva Dinakar, Hitesh Kumar, Rupshee Jain, Sharyu Kesharwani, Siddharth S Kesharwani, Shyam lal Mudavath, Ajmeer Ramkishan, Vikas Jain. Therapeutic delivery of siRNA for the management of breast cancer and triple-negative breast cancer. Therapeutic Delivery 2024; 15(11): 871 doi: 10.1080/20415990.2024.2400044
|
| 48 |
Naranamangalam R. Jagannathan. Application of in vivo MR methods in the study of breast cancer metabolism. NMR in Biomedicine 2019; 32(10) doi: 10.1002/nbm.4032
|